Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

QoL and Treatment Compliance for Pre-menopausal Patients With HR+ Breast Cancer Using GnRHa as Ovarian Function Suppression(OFS) Treatment in the Chinese Population: a Real-world Observational Investigation

NCT05122377 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05122377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05122377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
QoL and Treatment Compliance for Pre-menopausal Patients With HR+ Breast Cancer Using GnRHa as Ovarian Function Suppression(OFS) Treatment in the Chinese Population: a Real-world Observational Investigation
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
March 1, 2022
Completion date
May 1, 2025
Enrollment
562 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, hormone receptor-positive breast cancer, quality of life